These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16684735)

  • 1. Mental health in the Medicare Part D drug benefit: a new regulatory model?
    Donohue J
    Health Aff (Millwood); 2006; 25(3):707-19. PubMed ID: 16684735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
    Morden NE; Garrison LP
    Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How beneficiaries fare under the new Medicare drug bill.
    Moon M
    Issue Brief (Commonw Fund); 2004 Jun; (730):1-16. PubMed ID: 15176395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Through the looking glass: the politics of the Medicare Prescription Drug, Improvement, and Modernization Act.
    Oberlander J
    J Health Polit Policy Law; 2007 Apr; 32(2):187-219. PubMed ID: 17463405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Siegel S
    Health Care Law Mon; 2004 Jan; ():3-14. PubMed ID: 14750394
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternative strategies for Medicare payment of outpatient prescription drugs--Part B and beyond.
    Danzon PM; Wilensky GR; Means KE
    Am J Manag Care; 2005 Mar; 11(3):173-80. PubMed ID: 15786856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in mental health cost growth: an expanded role for management?
    Frank RG; Goldman HH; McGuire TG
    Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic grand rounds: the economics of the new medicare drug benefit: implications for people with mental illnesses.
    Donohue JM
    Psychiatr Serv; 2005 Jun; 56(6):645-7. PubMed ID: 15939937
    [No Abstract]   [Full Text] [Related]  

  • 10. The Medicare Prescription Drug Improvement and Modernization Act of 2003: summary analysis and preliminary assessment of implications for radiology.
    Moran DW
    J Am Coll Radiol; 2004 May; 1(5):322-30. PubMed ID: 17411596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
    Docherty JP; Browne RA; Farmer M
    Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular medicine, the Medicare drug benefit, and the need for cost control.
    Gillick MR
    J Am Geriatr Soc; 2006 Sep; 54(9):1442-6. PubMed ID: 16970656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases in Medicare prescription drug plan costs attributable to psychotropic medications.
    Zivin K; McCammon RJ; Davis MM; Halasyamani LK; Kales HC
    Am J Geriatr Psychiatry; 2008 Aug; 16(8):674-85. PubMed ID: 18669946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy utilization and the Medicare Modernization Act.
    Maio V; Pizzi L; Roumm AR; Clarke J; Goldfarb NI; Nash DB; Chess D
    Milbank Q; 2005; 83(1):101-30. PubMed ID: 15787955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare prescription drugs: a benefit whose time has come.
    Benjamin GC
    Physician Exec; 1999; 25(4):89-90. PubMed ID: 10557496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit.
    West JC; Wilk JE; Muszynski IL; Rae DS; Rubio-Stipec M; Alter CL; Narrow WE; Regier DA
    Am J Psychiatry; 2007 May; 164(5):789-96. PubMed ID: 17475738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Private plans in medicare: another look.
    Gold M
    Health Aff (Millwood); 2005; 24(5):1302-10. PubMed ID: 16162577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining a future for fee-for-service Medicare.
    Foote SB; Halaas GW
    Health Aff (Millwood); 2006; 25(3):864-8. PubMed ID: 16684754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare part D and decompensation.
    Park JM; Hariprasad R; Park LT
    Psychiatr Serv; 2006 May; 57(5):722-3. PubMed ID: 16675773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.